1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gesell, J.J.
Zasloff, M.
Opella, S.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
9
127
135
10.1023/A:1018698002314
9090128
Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.
1997
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2469.945
MAGAININ 2
1
syn
polymer
no
yes
GIGKFLHSAKKFGKAFVGEIMNS(NH2)
GIGKFLHSAKKFGKAFVGEIMNSX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
Structure summary
1
0
1998-04-08
1
1
2008-03-24
1
2
2011-07-13
1
3
2016-10-26
Y
1997-12-19
REL
THE PEPTIDE WAS PREPARED BY SOLID-PHASE SYNTHESIS
8355
African clawed frog
Xenopus laevis
sample
LOWEST ENERGY
50
10
NOESY
TOCSY
DQF-COSY
4.1
303
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
DISTANCE GEOMETRY, SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR INTERFACED THROUGH NMRCOMPASS
NMRCOMPASS
structure solution
BIOSYM NMRCOMPASS
NMRCOMPASS
600
Bruker
DMX600
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
GLY
3
n
3
GLY
3
A
LYS
4
n
4
LYS
4
A
PHE
5
n
5
PHE
5
A
LEU
6
n
6
LEU
6
A
HIS
7
n
7
HIS
7
A
SER
8
n
8
SER
8
A
ALA
9
n
9
ALA
9
A
LYS
10
n
10
LYS
10
A
LYS
11
n
11
LYS
11
A
PHE
12
n
12
PHE
12
A
GLY
13
n
13
GLY
13
A
LYS
14
n
14
LYS
14
A
ALA
15
n
15
ALA
15
A
PHE
16
n
16
PHE
16
A
VAL
17
n
17
VAL
17
A
GLY
18
n
18
GLY
18
A
GLU
19
n
19
GLU
19
A
ILE
20
n
20
ILE
20
A
MET
21
n
21
MET
21
A
ASN
22
n
22
ASN
22
A
SER
23
n
23
SER
23
A
NH2
24
n
24
NH2
24
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ILE
2
-76.69
26.44
1
A
LYS
10
-63.61
-70.35
2
A
ASN
22
-72.20
-87.53
3
A
ILE
2
-75.92
27.79
5
A
ILE
2
-82.28
32.35
5
A
PHE
5
-47.38
-70.97
6
A
ASN
22
-39.69
-86.65
7
A
ASN
22
-69.12
-84.87
10
A
ASN
22
96.24
52.45
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
MAGAININ 2
NMR STRUCTURE OF MAGAININ 2 IN DPC MICELLES, 10 STRUCTURES
1
Y
N
A
LYS
4
A
LYS
4
HELX_P
A
MET
21
A
MET
21
1
1
18
covale
1.345
A
NH2
24
A
N
NH2
24
1_555
A
SER
23
A
C
SER
23
1_555
ANTIBIOTIC
ANTIBIOTIC, MAGAININ, MEMBRANE, AMPHIPATHIC HELIX, MICELLE
MAGA_XENLA
UNP
1
1
P11006
MFKGLFICSLIAVICANALPQPEASADEDMDEREVRGIGKFLHSAGKFGKAFVGEIMKSKRDAEAVGPEAFADEDLDERE
VRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGP
EAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFADEDFDEREVRGIGKFLHSAKKFGKAFVGEI
MNSKRDAEAVGPEAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVDDRRWVE
267
289
2MAG
1
23
P11006
A
1
1
23
BINDING SITE FOR RESIDUE NH2 A 24
Software
1
A
SER
23
A
SER
23
1
1_555
1
P 1